Log in to search using one of your social media accounts:

HSMN NewsFeed HSMN NewsFeed RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Spero Therapeutics Appoints Joel Sendek as Chief Financial Officer
Carol Waldo Also Joins Leadership Team as Head of Regulatory Affairs CAMBRIDGE, Mass., May 22, 2017 -- (Healthcare Sales & Marketing Network) -- Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment o... Biopharmaceuticals, Personnel Spero Therapeutics, multidrug resistant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2017 Category: Pharmaceuticals Source Type: news

Telemedicine Innovator Lemonaid Health Raises $11 Million in Series A Funding
SAN FRANCISCO, May 22, 2017 -- (Healthcare Sales & Marketing Network) -- Lemonaid Health, the simplest and fastest platform for online healthcare, today announced $11 million in new funding to support continued innovation in affordable online healthcare. ... Devices, Venture Capital Lemonaid Health, telemedicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2017 Category: Pharmaceuticals Source Type: news

Thermo Fisher Scientific Introduces Latest in Capillary Electrophoresis Technology with new Applied Biosystems(TM) SeqStudio(TM) Genetic Analyzer
New low-throughput Sanger sequencing and fragment analysis platform offers trusted technology and workflow with all-in-one cartridge system and cloud connectivity SOUTH SAN FRANCISCO, Calif., May 22, 2017 -- (Healthcare Sales & Marketing Network) -- Th... Diagnostics, Product Launch Thermo Fisher Scientific, Capillary Electrophoresis, SeqStudio (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2017 Category: Pharmaceuticals Source Type: news

Bausch and Lomb Introduces renu(R) Advanced Formula Multi-Purpose Solution
New & Improved Formula Builds on Trusted 30-Year Heritage of Meeting Consumers' Lens Care Solution Needs LAVAL, Quebec, May 22, 2017 -- (Healthcare Sales & Marketing Network) -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wh... Biopharmaceuticals, Ophthalmology, Product Launch Bausch & Lomb, Valeant Pharmaceuticals, renu Advanced Formula (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2017 Category: Pharmaceuticals Source Type: news

Bluejay Diagnostics' Board Of Directors Announces Appointment Of Douglas C. Wurth As Chairman
ACTON, Mass., May 22, 2017 -- (Healthcare Sales & Marketing Network) -- Bluejay Diagnostics, Inc. (Bluejay) today announced that its board of directors unanimously named Douglas C. Wurth as the Company's chairman, effective immediately. Mr. Wurth rece... Diagnostics, Personnel Bluejay Diagnostics, Allereye, Conjunctivitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2017 Category: Pharmaceuticals Source Type: news

BONESUPPORT Announces First Patient Enrolled in FORTIFY Trial With CERAMENT G, a Novel Injectable, Antibiotic-eluting Bone Graft Substitute
FORTIFY trial to assess CERAMENT G as part of the surgical repair of severe tibial fractures LUND, Sweden, May 22, 2017 -- (Healthcare Sales & Marketing Network) -- BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute ... Devices, Orthopaedic BONESUPPORT, bioceramic bone substitute, CERAMENT G (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2017 Category: Pharmaceuticals Source Type: news

Amgen And UCB Announce Top-Line Phase 3 Data From Active-Comparator Study Of EVENITY(TM) (Romosozumab) In Postmenopausal Women With Osteoporosis
ARCH Study Met Primary and Key Secondary Endpoints by Reducing the Incidence of New Vertebral, Clinical and Non-Vertebral Fractures Imbalance in Cardiovascular Events Observed as New Safety Signal THOUSAND OAKS, Calif. and BRUSSELS, May 21, 2017 -- (... Biopharmaceuticals Amgen, UCB , romosozumab, EVENITY, osteoporosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2017 Category: Pharmaceuticals Source Type: news

Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar
Positive opinion based on a clinical development program involving over 1,000 people with type 1 or type 2 diabetes Paris, France - May 19, 2017 - Sanofi announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medi... Biopharmaceuticals, Regulatory Sanofi, Insulin lispro, Biosimilar (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 19, 2017 Category: Pharmaceuticals Source Type: news

Iterum Secures $65 Million in Series B Financing
Funding to support the Phase 3 clinical development of oral penem antibiotic DUBLIN and CHICAGO, May 19, 2017 -- (Healthcare Sales & Marketing Network) -- Iterum Therapeutics Limited, an Irish clinical-stage pharmaceutical company focused on the develo... Biopharmaceuticals, Venture Capital, Personnel Iterum Therapeutics, sulopenem (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 19, 2017 Category: Pharmaceuticals Source Type: news

Merck Receives CHMP Positive Opinion Recommending Approval of ISENTRESS(R) (raltegravir) 600 mg in the European Union
KENILWORTH, N.J.--(Healthcare Sales & Marketing Network)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted... Biopharmaceuticals, Regulatory Merck, ISENTRESS, raltegravir, HIV/AIDS (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 19, 2017 Category: Pharmaceuticals Source Type: news

First AxioMed Viscoelastic Total Disc Replacement Implanted in Sydney, Australia
AxioMed is pleased to announce the success of the first viscoelastic Freedom cervical case in Sydney. Malden, Mass. (Healthcare Sales & Marketing Network) May 18, 2017 -- Dr. Ralph Mobbs of the Neuro Spine Clinic completed the procedure on April 28, 201... Devices, Orthopaedic, Neurosurgery AxioMed, viscoelastic disc, Freedom Cervical Disc, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 19, 2017 Category: Pharmaceuticals Source Type: news

Biotheranostics Appoints Don Hardison as New CEO
Diagnostics Industry Leader Steps Up from Board of Directors to Bolster Reimbursement Position, Expand Clinical Utility of Diagnostic Tools SAN DIEGO, May 18, 2017 -- (Healthcare Sales & Marketing Network) -- Biotheranostics, Inc., a growing molecular ... Diagnostics, Personalized Medicine, Personnel Biotheranostics, Breast Cancer Index, CancerTYPE ID (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 18, 2017 Category: Pharmaceuticals Source Type: news

Amgen Submits Biologics License Application To The FDA For Erenumab
Erenumab is an Investigative Treatment Specifically Designed to Prevent Migraine Only Molecule in Late-Stage Development to Directly Target the Calcitonin Gene-Related Peptide Receptor Amgen and Novartis to Co-Commercialize Erenumab in the U.S. TH... Biopharmaceuticals, Neurology, FDA Amgen, erenumab, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 18, 2017 Category: Pharmaceuticals Source Type: news

EnteroMedics Announces First vBloc(R) Neurometabolic Therapy Implant at McGuire Veterans Affairs Medical Center
ST. PAUL, Minn., May 18, 2017 -- (Healthcare Sales & Marketing Network) -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today a... Devices, Neurology EnteroMedics, vBloc , Neurometabolic Therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 18, 2017 Category: Pharmaceuticals Source Type: news

New Hill-Rom(R) 900 Accella(TM) Bed Enhances Patient Care
Now available in select markets outside the U.S., new bed system designed for higher acuity settings improves safety, outcomes, and patient experience CHICAGO, May 18, 2017 -- (Healthcare Sales & Marketing Network) -- Hill-Rom Holdings, Inc. (NYSE: HRC... Devices, Product Launch Hill-Rom Holdings, Hill-Rom 900 Accella, bed system (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 18, 2017 Category: Pharmaceuticals Source Type: news

Swedish Orphan Biovitrum AB - Elocta(R) Approved in the Kingdom of Saudi Arabia for the Treatment of Haemophilia A
STOCKHOLM, May 18, 2017 -- (Healthcare Sales & Marketing Network) -- Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that the Saudi Food & Drug Authority (SFDA) in the Kingdom of Saudi Arabia has approved Elocta® (efmoroctocog alfa), a reco... Biopharmaceuticals, Regulatory Swedish Orphan Biovitrum, Sobi , Elocta , haemophilia A (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 18, 2017 Category: Pharmaceuticals Source Type: news

Pharmalink AB Announces the Appointment of a New Chief Executive Officer
Pharmalink AB, a specialty pharmaceutical company, announces the appointment of Renee Aguiar-Lucander as Chief Executive Officer. STOCKHOLM, May 18, 2017 -- (Healthcare Sales & Marketing Network) -- Pharmalink has appointed Ms Aguiar-Lucander to lead t... Biopharmaceuticals, Personnel Pharmalink AB, Nefecon (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 18, 2017 Category: Pharmaceuticals Source Type: news

Sera Prognostics Appoints Nadia Altomare as Chief Commercial Officer
SALT LAKE CITY, May 17, 2017 -- (Healthcare Sales & Marketing Network) -- Sera Prognostics, Inc., a women’s healthcare company, announced today that Nadia F. Altomare has joined the company as chief commercial officer. Ms. Altomare will lead all commercia... Diagnostics, Personnel Sera Prognostics, PreTRM, preterm birth (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2017 Category: Pharmaceuticals Source Type: news

Statement Regarding Xifaxan Intellectual Property Litigation
LAVAL, Quebec, May 17, 2017 -- (Healthcare Sales & Marketing Network) -- Salix Pharmaceuticals, Inc. and parent Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") and Actavis Laboratories, Inc., at Actavis' request,... Biopharmaceuticals, Litigation Valeant Pharmaceuticals, Actavis Laboratories, Xifaxan, rifaximin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2017 Category: Pharmaceuticals Source Type: news

Caris Life Sciences Appoints John Marshall, M.D., as Chief Medical Officer
IRVING, Texas, May 17, 2017 -- (Healthcare Sales & Marketing Network) -- Caris Life Sciences, a leading innovator in molecular science, today announced the appointment of John Marshall, M.D., as its Chief Medical Officer. Dr. Marshall will direct the comp... Diagnostics, Personalized Medicine, Personnel Caris Life Sciences, Genomic Profiling, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2017 Category: Pharmaceuticals Source Type: news

Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher and Paykel
SAN DIEGO – May 17, 2017 -- (Healthcare Sales & Marketing Network) -- ResMed today issued the following statement from David Pendarvis, the company’s global general counsel and chief administrative officer: “ResMed filed a motion to dismiss the current ... Devices, Litigation ResMed, Fisher & Paykel, sleep apnea, chronic obstructive pulmonary disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2017 Category: Pharmaceuticals Source Type: news

Xeltis' Technology for Natural Heart Valve Restoration Featured as the Future of Valve Therapy at EuroPCR
Dedicated plenary session on Endogenous Tissue Restoration (ETR) previews first data from aortic valve preclinical studies PARIS, May 17, 2017 -- (Healthcare Sales & Marketing Network) -- A pioneering approach to heart valve therapy from Swiss-Dutch cl... Devices, Interventional, Cardiology Xeltis , Endogenous Tissue Restoration, heart valve therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2017 Category: Pharmaceuticals Source Type: news

Edwards' Novel Self-Expanding Transcatheter Heart Valve Demonstrates Excellent Early Patient Outcomes
PARIS, May 17, 2017 -- (Healthcare Sales & Marketing Network) -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced late-breaking data at... Devices, Interventional, Cardiology Edwards Lifesciences, transcatheter aortic valve replacement, CENTERA valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2017 Category: Pharmaceuticals Source Type: news

Dragonfly Therapeutics Announces Head of Biology
Dragonfly announces that Dr. Ann Cheung will become its Head of Biology, leading critical development of the company's novel Natural Killer cell-based immunotherapies. CAMBRIDGE, Mass., May 16, 2017 -- (Healthcare Sales & Marketing Network) -- Dragonf... Biopharmaceuticals, Oncology, Personnel Dragonfly Therapeutics, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2017 Category: Pharmaceuticals Source Type: news

Introducing the Softest CPAP Mask from ResMed
ResMed’s AirTouch™ F20 full face mask with UltraSoft™ memory foam keeps patients on CPAP therapy comfortable throughout the night SAN DIEGO – May 16, 2017 – ResMed (NYSE: RMD) today announced its AirTouch F20 full face mask with UltraSoft memory foam ma... Devices, Product Launch ResMed, AirTouch, CPAP Mask, CPAP (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2017 Category: Pharmaceuticals Source Type: news

Thermo Fisher Scientific's One Lambda Brand Signs Exclusive Licensing Agreement with Transcriptome Sciences Inc. for access to Molecular Microscope Diagnostic System
CANOGA PARK, Calif., May 16, 2017 -- (Healthcare Sales & Marketing Network) -- One Lambda, a Thermo Fisher Scientific brand, announced today that it has signed an exclusive licensing agreement with Transcriptome Sciences Inc. (TSI) of Edmonton, Canada fo... Diagnostics, Oncology, Licensing Thermo Fisher Scientific, One Lambda, Molecular Microscope (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2017 Category: Pharmaceuticals Source Type: news

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience
MiStent Data the Subject of Three EuroPCR 2017 Presentations PARIS, May 16, 2017 -- (Healthcare Sales & Marketing Network) -- Micell Technologies announced today at the late-breaking trial session of EuroPCR – the official congress of the European Asso... Devices, Interventional, Cardiology Micell Technologies, DESSOLVE III, MiStent, Sirolimus, drug eluting stent (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2017 Category: Pharmaceuticals Source Type: news

The Boston Scientific LOTUS(TM) Valve System Demonstrated Superior Efficacy to CoreValve(R) in Global REPRISE III Trial at One Year
PARIS and MARLBOROUGH, Mass., May 16, 2017 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (NYSE: BSX) today announced positive results from the REPRISE III clinical trial, presented at the annual EuroPCR Scientific Program, in Paris. Data... Devices, Interventional, Cardiology Boston Scientific, REPRISE III, LOTUS Valve, TAVI (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2017 Category: Pharmaceuticals Source Type: news

Philips showcases new integrated image-guided therapy solutions at 2017 EuroPCR to transform cardiac care and help improve patient care
Highlights Philips Azurion, the next generation image guided therapy platform to optimize system integration and lab performance Launches unique portfolio of iFR co-registration technologies, including iFR Roadmap and SyncVision, to enhance stenting str... Devices, Interventional, Cardiology, Radiology Royal Philips, angioplasty, iFR Roadmap, SyncVision iFR (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2017 Category: Pharmaceuticals Source Type: news

Boston Scientific Closes Symetis Acquisition
Acquisition Expands Company's Structural Heart Portfolio; Increases Offerings for the Treatment of Patients with Valvular Heart Disease MARLBOROUGH, Mass., May 16, 2017 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: B... Devices, Interventional, Cardiology, Mergers & Acquisitions Boston Scientific, Symetis SA, transcatheter aortic valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2017 Category: Pharmaceuticals Source Type: news

Cerecor Appoints Steven Boyd and Peter Greenleaf to Board of Directors
BALTIMORE, MD-- (Healthcare Sales & Marketing Network) -- Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing treatments to make a difference in the lives of patients with neurological and psychiatric disorders, today announc... Biopharmaceuticals, Neurology, Personnel Cerecor, opioid receptor antagonist, major depressive disorder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2017 Category: Pharmaceuticals Source Type: news

Alcobra Announces Leadership Update
Dr. Yaron Daniely to Step Down as Chief Executive Officer, Effective May 31, 2017 David Baker Named Interim Chief Executive Officer Dr. Daniely to Remain on Board of Directors and be Appointed Chairman TEL AVIV, Israel, May 15, 2017 -- (Healthcare... Biopharmaceuticals, Personnel Alcobra, MDX, ADAIR (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2017 Category: Pharmaceuticals Source Type: news

Formation Biologics Announces Dosing of First Patient in a Phase I/IIa Trial of AVID100, Closing of Series B Financing, and Appointment of Dr. Anthony Tolcher to its Board of Directors
AUSTIN, TX and MONTREAL, May 15, 2017 -- (Healthcare Sales & Marketing Network) - Formation Biologics, a clinical stage biopharmaceutical company, today announces the start of a multi-center, Phase I/IIa trial evaluating AVID100 in patients with epidermal... Biopharmaceuticals, Venture Capital, Personnel Formation Biologics, EGFR (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2017 Category: Pharmaceuticals Source Type: news

Nuvo Pharmaceuticals(TM) Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid(R) 2%
Pennsaid 2% Already Approved for Marketing in the United States and Russia MISSISSAUGA, ON, May 15, 2017 -- (Healthcare Sales & Marketing Network) - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI), a commercial healthcare company with a portf... Biopharmaceuticals Nuvo Pharmaceuticals, Pennsaid, diclofenac, ankle, sprain (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2017 Category: Pharmaceuticals Source Type: news

BiomX Raises $24 Million in Series A Funding to Develop Microbiome Therapeutics
Funds will be used for advancing Company's novel therapeutic pipeline and enhancing its unique microbiome modulation platform technologies NESS ZIONA, Israel, May 15, 2017 -- (Healthcare Sales & Marketing Network) -- BiomX Ltd., a leading microbiome th... Biopharmaceuticals, Venture Capital BiomX, microbiome, microbiome therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2017 Category: Pharmaceuticals Source Type: news

Ionis Pharmaceuticals Announces Phase 3 NEURO-TTR Study of Inotersen (IONIS-TTR Rx) Meets Both Primary Endpoints
Webcast to Discuss Results May 15, 2017 at 8:30 am ET CARLSBAD, Calif., May 15, 2017 -- (Healthcare Sales & Marketing Network) -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that the Phase 3 NEURO-TTR study of inotersen (IONIS-TTRRx) in ... Biopharmaceuticals Ionis Pharmaceuticals, inotersen, IONIS-TTRRx, familial amyloid polyneuropathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2017 Category: Pharmaceuticals Source Type: news

Integra LifeSciences launches SurgiMend(R) MP Collagen Matrix for Hernia Repair
SurgiMend MP is a collagen matrix for soft tissue reconstruction, featuring a highly macroporous design PLAINSBORO, N.J., May 12, 2017 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading globa... Devices, Surgery, Product Launch Integra LifeSciences, SurgiMend MP, collagen matrix, hernia repair (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 12, 2017 Category: Pharmaceuticals Source Type: news

Millipede, Inc. Announces Successful Clinical Use of the First Adjustable, Retrievable Transcatheter Complete Mitral Annuloplasty Ring
Transcatheter Procedures Mark Important Milestone in Clinical Program and Expanding Access for Patients SANTA ROSA, Calif., May 12, 2017 -- (Healthcare Sales & Marketing Network) -- Millipede, Inc., an innovator in the field of transcatheter mitral and... Devices, Interventional, Cardiology Millipede, IRIS Complete Annuloplasty Ring, transcatheter, mitral valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 12, 2017 Category: Pharmaceuticals Source Type: news

Lilly Announces Positive Results for Three Phase 3 Studies of Galcanezumab for the Prevention of Episodic and Chronic Migraine
INDIANAPOLIS, May 12, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) announced today that galcanezumab, an investigational treatment for the prevention of episodic and chronic migraine, met its primary endpoint in thre... Biopharmaceuticals, Neurology Eli Lilly, migraine, galcanezumab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 12, 2017 Category: Pharmaceuticals Source Type: news

Capricor Therapeutics Provides Update on ALLSTAR Trial
Unlikely to Achieve Primary Efficacy Endpoint of Change in Infarct Size in Patients Following Heart Attack Capricor to Focus on Potential Registration Program in Duchenne Muscular Dystrophy Company to Hold Conference Call Today at 5:00 AM PDT / 8:00 ... Regenerative Medicine, Cardiology Capricor Therapeutics, ALLSTAR Trial, allogeneic cardiosphere-derived cells (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 12, 2017 Category: Pharmaceuticals Source Type: news

Ardelyx Reports Successful Phase 3 T3MPO-1 Trial of Tenapanor in Patients with IBS-C
Study achieves primary endpoint; tenapanor well-tolerated in treated patients Company to hold conference call at 8:30 a.m. ET today FREMONT, Calif., May 12, 2017 -- (Healthcare Sales & Marketing Network) -- Ardelyx, Inc. (NASDAQ: ARDX), a late-stage... Biopharmaceuticals, Gastroenterology Ardelyx, T3MPO-1 trial, IBS-C, tenapanor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 12, 2017 Category: Pharmaceuticals Source Type: news

Xencor's Lead Drug Candidate, XmAb5871, Receives Orphan Drug Designation from FDA for Treatment of IgG4-Related Disease
MONROVIA, Calif., May 11, 2017 -- (Healthcare Sales & Marketing Network) -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic d... Biopharmaceuticals, FDA Xencor, XmAb, IgG4-Related Disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 11, 2017 Category: Pharmaceuticals Source Type: news

Rhythm Receives Expanded FDA Breakthrough Therapy Designation for Setmelanotide for Rare Genetic Disorders of Obesity
New designation for the treatment of obesity associated with genetic defects upstream of the MC4 receptor in the leptin-melanocortin pathway Expands upon previous designation for POMC deficiency obesity BOSTON, May 11, 2017 -- (Healthcare Sales & Mar... Biopharmaceuticals, FDA Rhythm Pharmaceuticals, setmelanotide, obesity (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 11, 2017 Category: Pharmaceuticals Source Type: news

New Data Reinforce Benefits of TomoTherapy(R) Platform for Mainstream Radiation Therapy Treatment Indications
Multiple Studies Presented at ESTRO 36 Demonstrate System Improves Tumor Control withReduced Toxicities SUNNYVALE, Calif., May 11, 2017 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced today that studies contin... Devices, Oncology Accuray, TomoTherapy, radiotherapy, IMRT (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 11, 2017 Category: Pharmaceuticals Source Type: news

STAAR Surgical Announces CE Mark Approval for the EVO+ Visian ICL with Aspheric (EDOF) Optic
MONROVIA, Calif., May 11, 2017 -- (Healthcare Sales & Marketing Network) -- STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, has received CE Mark for its... Devices, Ophthalmology, Regulatory STAAR Surgical, EVO+ Visian ICL, Aspheric, Implantable Collamer Lens (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 11, 2017 Category: Pharmaceuticals Source Type: news

New MRI Data from Asterias' Ongoing SCiStar Clinical Study Indicates AST-OPC1 Cells Prevent Formation of Damaging Lesion Cavities in Patients Suffering Severe Spinal Cord Injury
MRI scans are consistent with durable engraftment of AST-OPC1 cells in the damaged area of the spinal cord and show the potential of AST-OPC1 to reduce spinal cord tissue deterioration after severe spinal cord injury These disease-modifying aspects of A... Regenerative Medicine, Neurosurgery Asterias Biotherapeutics, AST-OPC1, SCiStar, spinal cord injury, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 11, 2017 Category: Pharmaceuticals Source Type: news

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers
Portfolio of Next Generation Heart Failure Devices Offers Effective Pacing and Access to the Most Advanced Diagnostic Imaging Procedures DUBLIN - May 10, 2017 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT) has received U.S. Food a... Devices, Cardiology, Radiology, FDA Medtronic, cardiac resynchronization therapy, pacemaker, magnetic resonance (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2017 Category: Pharmaceuticals Source Type: news

Savara Announces Expedited U.S. Molgradex Development Strategy
Ongoing IMPALA Study to be Expanded to Serve as Global Pivotal Study for Registration AUSTIN, Texas, May 10, 2017 -- (Healthcare Sales & Marketing Network) -- Savara Inc. (NASDAQ: SVRA) today announced that it has received guidance from the U.S. Food a... Biopharmaceuticals, FDA Savara, Molgradex, pulmonary alveolar proteinosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2017 Category: Pharmaceuticals Source Type: news

Leigh Ann Pusey Joins Lilly as Senior Vice President of Corporate Affairs and Communications
Insurance industry veteran will lead Lilly public affairs and lobbying efforts INDIANAPOLIS, May 10, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) announced today that Leigh Ann Pusey will be joining Lilly as senio... Biopharmaceuticals, Personnel Eli Lilly (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2017 Category: Pharmaceuticals Source Type: news

Varian ProBeam Proton Therapy System Receives Shonin Approval
Advanced proton therapy systems from Varian now available to cancer centers in Japan PALO ALTO, Calif., May 10, 2017 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (NYSE: VAR) today announced it has received Shonin approval from th... Devices, Oncology, Regulatory Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2017 Category: Pharmaceuticals Source Type: news